新天药业:转让4个药品上市许可及相关生产技术给信安堂集团

Core Viewpoint - The company has approved the transfer of drug marketing licenses and related production technologies for four products to Guizhou Xinan Tang Group Pharmaceutical Co., Ltd. during a board meeting scheduled for January 27, 2026 [1] Group 1 - The board of directors has agreed to transfer the marketing licenses and production technologies for "Nai Le Jing Granules," "Nai Le Jing Capsules," "Cold and Cough Capsules," and "Regulating Menstruation and Activating Blood Capsules" [1]

Xintian Pharma-新天药业:转让4个药品上市许可及相关生产技术给信安堂集团 - Reportify